Microglia in Neuroinflammation and Neurodegeneration: From Understanding to Therapy.
Level 5 - mechanism / opinion, no new human data
Narrative review of biological mechanisms without systematic search methodology or primary clinical data
PubMed 34630027 · doi:10.3389/fnins.2021.742065
What was done
This narrative review synthesizes literature on microglial development, homeostatic roles in synaptic sculpting and neural precursor support, and single-cell transcriptome findings following central nervous system injury across neurodegenerative conditions including multiple sclerosis, Alzheimer's disease, Parkinson's disease, and amyotrophic lateral sclerosis.
What was found
The abstract reports no numerical data, effect sizes, or study counts. It qualitatively notes that microglia alter morphology and downregulate homeostatic genes after CNS injury, but emphasizes that their specific protective versus detrimental functional roles in disease progression remain to be fully clarified.
Why it matters
Understanding the molecular shifts of microglia during neuroinflammation highlights shared therapeutic targets for modulating neurodegeneration across multiple central nervous system disorders.
Limits
The abstract describes a narrative review without systematic search criteria, meta-analytic pooling, or new empirical data. Specific quantitative findings and clinical efficacy endpoints are not reported.
Cited by
- supports Microglial cells in their supportive state maintain synapses, neuronal function, and the blood-brain barrier.